PLEASE READ these important registration notices:
- By registering and purchasing access to this live, in-person, face-to-face event, you are agreeing to ASCCP's COVID-19 And Any Other Communicable Or Infectious Disease: Liability Waiver.
- By registering and purchasing access to this event, you agree to allow ASCCP to share your name and address with our exhibitors.
- ASCCP is Going Green. A few days before the course, you will receive an email with links to the course program and the slide decks. Please download any documents you need before coming on-site (wifi in the hotel is typically not strong enough to download these large files). If you prefer print, please print your hardcopies and bring them with you.
- Food Allergies and Vegetarian Requirements: Please email meetings@asccp.org with your request at least two weeks before the start of the course. Any requests made after this date may not be able to be accommodated. No requests will be accepted on site.
Is this educational activity right for me?
This evidence-based course is designed for the beginning/intermediate colposcopist. It will also benefit clinicians needing updated information about the Cervical Cancer Screening Guidelines, the ASCCP Consensus Guidelines for Management of Women with Abnormal Cervical Cancer Screening Tests and Cancer Precursors, and new concepts about HPV screening and triage, treatment methods, and HPV epidemiology. This course is designed to improve competencies in medical knowledge, practice-based learning, patient outcomes, and/or systems-based practice. It is recommended the participant be a licensed physician or advanced practice clinician with an advanced clinical degree from an accredited institution and who makes gynecologic diagnosis and management decisions as the course is paced for these clinicians.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
-
Describe the anatomy, cytology, histology, and colposcopic findings of the normal and abnormal cervix, vagina, and vulva (medical knowledge).
-
Elicit and document an appropriate history including risk factors for lower genital tract neoplasia (medical knowledge, practice-based learning).
-
Define the pathophysiology of lower genital tract neoplasia, including the role of oncogenic HPV in preinvasive and invasive diseases of the cervix, vagina, and vulva (medical knowledge).
-
Define the Bethesda System of cervicovaginal terminology (medical knowledge).
-
Apply new standards for cervical cancer screening, including HPV testing (systems-based practice).
-
Describe the prevention of cervical neoplasia and genital warts using prophylactic HPV vaccines (medical knowledge).
-
Discuss the challenges of colposcopy and management of cervical neoplasia for selected patient populations such as adolescents, women infected with HIV, underserved women, and pregnant women (medical knowledge, practice-based learning, patient outcomes).
-
Perform appropriate cytologic sampling, colposcopic evaluation, and biopsies (including endocervical sampling), and become familiar with instrumentation and necessary supplies (practice-based learning).
-
Recognize the diagnostic characteristics of cervical abnormalities (low-grade and high-grade cervical lesions as well as adenocarcinoma in-situ and cervical cancer) on cytologic, colposcopic, and histologic exam (practice-based learning).
-
Interpret and correlate cytologic, colposcopic, and histologic results (practice-based learning).
-
Formulate a plan of care for the management of women with Pap test abnormalities according to the most recent ASCCP Consensus Guidelines, the ASCUS/LSIL Triage Study (ALTS), and other evidence-based guidelines (practice-based learning, systems-based practice, patient outcomes).
-
Describe, but not perform, treatment options to include cryosurgery and electrosurgical loop excision procedure (LEEP) of the cervix (practice-based learning).
-
Summarize and explain the diagnosis and management of vulvar and vaginal neoplasia (medical knowledge, practice-based learning).
-
Provide appropriate patient education and support (medical knowledge, interpersonal and communication skills).
After successfully completing the course, participants are expected to partake in a hands-on mentored performance training as required for credentialing in new procedures by their home institutions, as this course alone will not prepare participants for independent practice.
3705 Spectrum Boulevard Tampa, Florida, 33612, USA
Phone: 813-977-7066
$179 / night
Cut-off Date: December 27, 2023
CME Info
Comprehensive Colposcopy Course
Is this educational activity right for me?
This evidence-based course is designed for the beginning/intermediate colposcopist. It will also benefit clinicians needing updated information about the newly published Updated Cervical Cancer Screening Guidelines, the Updated National Consensus Guidelines for Management of Women with Abnormal Cervical Cancer Screening Tests and Cancer Precursors, and new concepts about HPV screening and triage, treatment methods, and HPV epidemiology. This course is designed to improve competencies in medical knowledge, practice-based learning, patient outcomes, and/or systems-based practice. The participant should be a licensed physician or advanced practice clinician with an advanced clinical degree from an accredited institution and who makes gynecologic diagnosis and management decisions.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the anatomy, cytology, histology, and colposcopic findings of the normal and abnormal cervix, vagina, and vulva (medical knowledge);
- Elicit and document an appropriate history including risk factors for lower genital tract neoplasia (medical knowledge, practice-based learning);
- Define the pathophysiology of lower genital tract neoplasia, including the role of oncogenic HPV in preinvasive and invasive diseases of the cervix, vagina, and vulva (medical knowledge);
- Define the Bethesda System of cervicovaginal terminology (medical knowledge);
- Apply new standards for cervical cancer screening, including HPV testing (systems-based practice);
- Describe the prevention of cervical neoplasia and genital warts using prophylactic HPV vaccines (medical knowledge);
- Discuss the challenges of colposcopy and management of cervical neoplasia for selected patient populations such as adolescents, women infected with HIV, underserved women, and pregnant women (medical knowledge, practice-based learning, patient outcomes)
- Perform appropriate cytologic sampling, colposcopic evaluation, and biopsies (including endocervical sampling), and become familiar with instrumentation and necessary supplies (practice-based learning);
- Recognize the diagnostic characteristics of cervical abnormalities (low-grade and high-grade cervical lesions as well as adenocarcinoma in-situ and cervical cancer) on cytologic, colposcopic, and histologic exam (practice-based learning);
- Interpret and correlate cytologic, colposcopic, and histologic results (practice-based learning);
- Formulate a plan of care for the management of women with Pap test abnormalities according to the most recent ASCCP Consensus Guidelines, the ASCUS/LSIL Triage Study (ALTS), and other evidence-based guidelines (practice-based learning, systems-based practice, patient outcomes);
- Describe, but not perform, treatment options to include cryosurgery and electrosurgical loop excision procedure (LEEP) of the cervix (practice-based learning);
- Summarize and explain the diagnosis and management of vulvar and vaginal neoplasia (medical knowledge, practice-based learning); and,
- Provide appropriate patient education and support (medical knowledge, interpersonal and communication skills).
Continuing Medical Education (CME)
ACCME Accreditation Statement
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.
Credit Designation Statement
AMA PRA Category 1 Credit(s)TM ASCCP designates this live activity for a maximum of 22.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Information
All those who have an opportunity to control or influence content (Faculty, Program Directors, Reviewers, Staff, etc), are required to complete a disclosure form based on the following instructions:
ASCCP members and the general public place great trust in the work of the Society. Real or perceived undisclosed conflicts of interest may jeopardize that trust and ASCCP’s effectiveness. Conflicts of interest also may affect the objectivity of decisions that ASCCP officers and volunteers make. To minimize the potential impact of possible conflicts of interest, the Board of Directors has determined that all participants in ASCCP activities must report all real or potential conflicts prior to the activity being developed and delivered to the learners.
Additionally, the ACCME Standards for Integrity and Independence require that we disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education.
Please disclose all financial relationships that you have had in the past 24 months with ineligible companies (see definition below). For each financial relationship, enter the name of the ineligible company and the nature of the financial relationship(s). There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education.
An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For specific examples of ineligible companies visit accme.org/standards.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ASCCP any financial relationship(s) that have occurred within the prior 24 months with any ineligible companies. Financial relationships are defined as remuneration in any amount from ineligible companies in the form of grants, research support, consulting fees, salary, ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds), honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors, or other financial benefits. The intent of this disclosure is not to prevent individuals with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ASCCP has reviewed all disclosures and mitigated all relevant financial relationships that have been identified.
The following person(s) disclosed financial relationships:
-
Nancy Berman, MSN, ANP-BC, NCMP, FAANP - 1. Astellas Advisory Board/Speakers Bureau Honorarium 2. Myovant Advisory Board Honorarium 3. SCYNEXIS Advisory Board Honorarium
All of the financial relationships listed for these individuals have been mitigated.
The following person(s) disclosed no financial relationships:
- Michael Gold, MD
- Kathy McIntyre-Seltman, MD
- Daniel Chernaev, MD - AAFP, ACOG, WPATH Member
- Victor Feldbaum, MD - ACOG, AAGL, APGO/Creog Committee Member, ACOG Fellow Officer, FMA Delegate Speaker and Member
- Joe Pymm – Staff
- Liesl Robinson – Staff
Faculty
Nancy Berman, MSN, ANP-BC, NCMP, FAANP
Michigan Healthcare Professionals
Farmington Hills, MI
Daniel Chernaev, MD
BayCare Medical Group
Clearwater, FL
Victor Feldbaum, MD
Bayfront Health
St. Petersburg, FL
Michael Gold, MD
University of Oklahoma School of Community Medicine
Tulsa, OK
Kathy McIntyre-Seltman, MD
UPMC Magee-Womens Hospital
Pittsburgh, PA
Not an ASCCP Member? Join now to get discounted registration.
Registration Type |
Early Bird (By 1/5/24) |
Regular |
ASCCP Physician Member |
$1,145.00 |
$1,245.00 |
Physician Non-Member |
$1,445.00 |
$1,545.00 |
ASCCP Physician Assistant, Nurse/Nurse Practitioner/Midwife, Researcher Member |
$1,045.00 |
$1,145.00 |
Physician Assistant, Nurse/Nurse Practitioner/Midwife, Researcher Non-Member |
$1,295.00 |
$1,395.00 |
ASCCP Trainee |
$645.00 |
$745.00 |
Trainee Non-Member* |
$745.00 |
$845.00 |
*Trainee Non-Members must submit proof that they are currently enrolled in a training program. Acceptable documents are a letter from your Department Chair or a Student ID.
Cancellation Policy: Written cancellation must be received at least 30 days prior to the start of the course. Any notice received by this time will be refunded, less a $100.00 administrative fee. No refunds will be made after this time.
Registration is non-transferable.
PLEASE READ these important registration notices:
- By registering and purchasing access to this live, in-person, face-to-face event, you are agreeing to ASCCP's COVID-19 And Any Other Communicable Or Infectious Disease: Liability Waiver.
- ASCCP is Going Green. A few days before the course, you will receive an email with links to the course program and the slide decks. Please download any documents you need before coming on-site (wifi in the hotel is typically not strong enough to download these large files). If you prefer print, please print your hardcopies and bring them with you.
- Food Allergies and Vegetarian Requirements: Please email meetings@asccp.org with your request at least two weeks before the start of the course. Any requests made after this date may not be able to be accommodated. No requests will be accepted on site.
Subject to Change
Wednesday
6:30 AM – 8:00 AM
Registration
7:00 AM – 8:00 AM
Continental Breakfast/Visit Exhibits
8:00 AM – 8:10 AM
Welcome and Opening Remarks
8:10 AM – 8:40 AM
The Normal Cervix: Cytology, Colposcopy, and Histology
8:40 AM – 9:15 AM
Epidemiology of HPV and Cervical Cancer
9:15 AM – 10:00 AM
Performing Cervical Cytology Tests
10:00 AM – 10:20 AM
Break/Visit Exhibits
10:20 AM – 11:05 AM
Cervical Cancer Screening: New Approaches
11:05 AM – 11:35 AM
The Evolution of Lower Genital Tract Terminology
11:35 AM – 12:05 PM
Questions & Answers
12:05 PM – 1:00 PM
Lunch
1:00 PM – 1:35 PM
Colposcopy: Equipment and Supplies
1:35 PM – 2:15 PM
Colposcopy: The Procedure
2:15 PM – 2:30 PM
Questions & Answers
2:30 PM – 3:00 PM
Break/Visit Exhibits
3:00 PM – 3:30 PM
HPV Vaccines
3:30 PM - 5:00 PM
- Breakout session A: Gallery of Images: The Normal Cervix, Squamous Metaplasia, and Transformation Zone
- Breakout session B: Common LGT Pathology Diagnosis
- Breakout Session C: Hands-On: "How to Focus"
Thursday
7:00 AM - 8:00 AM
Continental Breakfast/Visit Exhibits
8:00 AM - 8:15 AM
ASCCP Membership & the Colposcopy Mentorship Program
8:15 AM - 8:50 AM
Colposcopy of the Abnormal Transformation Zone
8:50 AM - 9:45 AM
ASC-US/LSIL/CIN1: Cytology, Colposcopy, and Histology with Case Stuides and ASCCP 2019 Risk-Based Management Consensus Guidelines
9:45 AM - 10:15 AM
Q&A
10:15 AM - 10:30 AM
Break/Visit Exhibits
10:30 AM - 11:30 AM
HSIL/CIN2, 3: Cytology, Colposcopy, and Histology with Case Studies and ASCCP 2019 Risk-Based Management Consensus Guidelines
11:30 AM - 12:45 PM
Lunch
12:45 PM - 1:15 PM
Assessment of Cervical Lesions: Determining Where to Biopsy
1:15 PM - 1:45 PM
Establishing U.S. Standards for Colposcopy Terminology and Practice
1:45 PM - 2:15 PM
Q&A
2:15 PM - 2:45 PM
Break/Visit Exhibits
2:45 PM - 5:00 PM
- Breakout session A: Interactive Case Discussion and Slide Identification
- Breakout session B: Selecting Where to Biopsy
- Breakout Session C: Condyloma, LSIL, HSIL and Cancer
Friday
7:00 AM - 7:45 AM
Continental Breakfast/Visit Exhibits
7:45 AM - 8:45 AM
Warning Signs of Cervical Cancer: Colposcopy and Management of Microinvasive and Squamous Cell Carcinoma
8:45 AM - 9:15 AM
Q&A
9:15 AM - 10:15 AM
Glandular Lesions: Cytology, Colposcopy, and Histology with Case Studies and ASCCP 2013 Management Guidelines
10:15 AM - 10:30 AM
Break/Visit Exhibits
10:45 AM - 11:15 AM
Cervical Treatment: Indications, Ablative and Excisional Techniques and Outcomes
11:15 AM - 11:45 AM
Adolescents and Young Women: A Unique Population
11:45 PM - 1:00 PM
Lunch
1:00 PM - 1:45 PM
Cervical Cancer Risk & Prevention for Immunocompromised Populations
1:45 PM - 2:15 PM
Colposcopy in Pregnancy
2:15 PM - 2:45 PM
Q&A
2:45 PM - 3:00 PM
Break
3:00 PM - 3:30 PM
Risk Based Management Consensus Guidelines
3:30 PM - 5:00 PM
- Workshop A: Colposcopes, Cervical Biopsy, ECC and instrumentation
- Workshop B: LEEP of the Cervix
- Workshop C: Interesting and Complex Cases
Saturday
7:00 AM - 8:00 AM
Continental Breakfast
8:00 AM - 8:15 AM
Management of Pre-Malignant and Malignant Diseases of the Vagina
8:15 AM - 8:45 AM
Benign Conditions of the Vulva and Condyloma
8:45 AM - 9:30 AM
Management of Neoplastic Diseases of the Vulva: VIN and Vulvar Cancer
9:30 AM - 9:45 AM
Q&A
9:45 AM - 10:00 AM
Break
10:00 AM - 10:30 AM
Case Studies Using the the ASCCP Risk-Based Management Consensus Guidelines
10:30 AM - 11:00 AM
Putting it All Together
Reserve Your Exhibit Booth Now!
|
|
|
|
|
ASCCP Colposcopy Courses are a great way to get your products in front of an interdisciplinary group of healthcare professionals, including physicians, physician assistants, and nurse practitioners.
Exhibitor Prospectus
|
Published on:
06/17/2024
Last Revised on:
11/06/2024